BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16288124)

  • 1. Impact of hysterectomy on endometrial carcinoma rates in the United States.
    Sherman ME; Carreon JD; Lacey JV; Devesa SS
    J Natl Cancer Inst; 2005 Nov; 97(22):1700-2. PubMed ID: 16288124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing endometrial cancer risk among US women: long-term trends using hysterectomy-adjusted analysis.
    Doll KM; Winn AN
    Am J Obstet Gynecol; 2019 Oct; 221(4):318.e1-318.e9. PubMed ID: 31125544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in endometrial cancer incidence by race and histology with a correction for the prevalence of hysterectomy, SEER 1992 to 2008.
    Jamison PM; Noone AM; Ries LA; Lee NC; Edwards BK
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):233-41. PubMed ID: 23239812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hysterectomy-corrected rates of endometrial cancer among women younger than age 50 in the United States.
    Temkin SM; Kohn EC; Penberthy L; Cronin KA; Rubinsak L; Dickie LA; Minasian L; Noone AM
    Cancer Causes Control; 2018 May; 29(4-5):427-433. PubMed ID: 29497884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers.
    Clarke MA; Devesa SS; Harvey SV; Wentzensen N
    J Clin Oncol; 2019 Aug; 37(22):1895-1908. PubMed ID: 31116674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women.
    Cote ML; Ruterbusch JJ; Olson SH; Lu K; Ali-Fehmi R
    Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1407-15. PubMed ID: 26290568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State-level uterine corpus cancer incidence rates corrected for hysterectomy prevalence, 2004 to 2008.
    Siegel RL; Devesa SS; Cokkinides V; Ma J; Jemal A
    Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):25-31. PubMed ID: 23125334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of ethnicity on the incidence of high-risk endometrial carcinoma.
    Plaxe SC; Saltzstein SL
    Gynecol Oncol; 1997 Apr; 65(1):8-12. PubMed ID: 9103384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of hospital volume on racial disparities and outcomes for endometrial cancer.
    Buskwofie A; Huang Y; Tergas AI; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2018 May; 149(2):329-336. PubMed ID: 29506862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009.
    Rositch AF; Nowak RG; Gravitt PE
    Cancer; 2014 Jul; 120(13):2032-8. PubMed ID: 24821088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of black race with receipt of hysterectomy and survival in low-risk endometrial cancer.
    Taylor KN; Li A; Manuel M; Rimel BJ; Kim KH
    Gynecol Oncol; 2023 Aug; 175():156-162. PubMed ID: 37390596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hysterectomy-corrected incidence rates of cervical and uterine cancers in Massachusetts, 1995 to 2010.
    Stang A; Hawk H; Knowlton R; Gershman ST; Kuss O
    Ann Epidemiol; 2014 Nov; 24(11):849-54. PubMed ID: 25241148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of comorbid conditions on racial disparities in endometrial cancer survival.
    Ruterbusch JJ; Ali-Fehmi R; Olson SH; Sealy-Jefferson S; Rybicki BA; Hensley-Alford S; Elshaikh MA; Gaba AR; Schultz D; Munkarah AR; Cote ML
    Am J Obstet Gynecol; 2014 Dec; 211(6):627.e1-9. PubMed ID: 24954655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial cancer in morbidly obese women: do racial disparities affect surgical or survival outcomes?
    Cote ML; Ruterbusch JJ; Ahmed Q; Bandyopadhyay S; Alosh B; Abdulfatah E; Seward S; Morris R; Ali-Fehmi R
    Gynecol Oncol; 2014 Apr; 133(1):38-42. PubMed ID: 24680590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials.
    Kopelman ZA; Tian C; Tumas J; Phippen NT; Tarney CM; Hope ER; Winkler SS; Jokajtys S; Kucera CW; Chan JK; Richardson MT; Kapp DS; Hamilton CA; Leath CA; Jones NL; Rocconi RP; Farley JH; Secord AA; Cosgrove CM; Powell MA; Klopp A; Walker JL; Fleming GF; Bateman NW; Conrads TP; Maxwell GL; Darcy KM
    Gynecol Oncol; 2024 Apr; 183():103-114. PubMed ID: 38593674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial disparities in high-risk uterine cancer histologic subtypes: A United States Cancer Statistics study.
    Abel MK; Liao CI; Chan C; Lee D; Rohatgi A; Darcy KM; Tian C; Mann AK; Maxwell GL; Kapp DS; Chan JK
    Gynecol Oncol; 2021 May; 161(2):470-476. PubMed ID: 33722415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences.
    Wu X; Chen VW; Andrews PA; Ruiz B; Correa P
    Cancer Causes Control; 2007 Aug; 18(6):585-93. PubMed ID: 17406989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparities in endometrial cancer outcomes between non-Hispanic White and Hispanic women.
    Rodriguez AM; Schmeler KM; Kuo YF
    Gynecol Oncol; 2014 Dec; 135(3):525-33. PubMed ID: 25449307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidities and endometrial cancer survival in Hispanics and non-Hispanic whites.
    Cook LS; Nelson HE; Cockburn M; Olson SH; Muller CY; Wiggins CL
    Cancer Causes Control; 2013 Jan; 24(1):61-9. PubMed ID: 23109171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2).
    Cote ML; Alhajj T; Ruterbusch JJ; Bernstein L; Brinton LA; Blot WJ; Chen C; Gass M; Gaussoin S; Henderson B; Lee E; Horn-Ross PL; Kolonel LN; Kaunitz A; Liang X; Nicholson WK; Park AB; Petruzella S; Rebbeck TR; Setiawan VW; Signorello LB; Simon MS; Weiss NS; Wentzensen N; Yang HP; Zeleniuch-Jacquotte A; Olson SH
    Cancer Causes Control; 2015 Feb; 26(2):287-296. PubMed ID: 25534916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.